QuidelOrtho will postpone its previously announced Investor Day

Michael Iskra has been appointed as the Interim Chief Executive Officer, and Robert Bujarski as the Interim President, effective February 21 . Both will continue to fulfill their current responsibilities while assuming the additional duties of their new roles. Kenneth F. Buechler, Ph.D., will remain as Chairman of the Board and will provide guidance to the Office of the CEO, supported by other Board members. “Now is the time for a change in leadership that can accelerate our initiatives to improve efficiencies, drive growth and increase shareholder value,” said Kenneth F. Buechler, Ph.D., Chairman of the Board. “All of us would like to thank Doug for his years of dedication and wish him well in his future endeavors.” The Board has started a comprehensive search to identify a new Chief Executive Officer, considering both internal and external candidates. There is no change to the Company’s financial guidance provided on February 16. Additionally, the Company will postpone its previously announced Investor Day until a later date.